Early Discharge in Patients Undergoing Elbow Arthroscopy
- Conditions
- Elbow Arthroscopy Surgery
- Registration Number
- NCT01151241
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
Patients undergoing elbow arthroscopy surgery will receive standard anesthesia and analgesia (infraclavicular nerve block combined with general anesthesia for surgery; continuous infusion via infraclavicular catheter to day 3 post op). Patients in the experimental group will be discharged home after one day, with infraclavicular catheter in place; patients in the comparator group will stay in hospital for 3 or 4 days, per standard practice. The study will compare range of motion as the primary endpoint, in a non-inferiority design, to see if early discharge is feasible while providing similar recovery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Patients undergoing elective complex arthroscopic elbow surgery requiring postoperative CPM - synovectomy, capsulectomy, extensive debridement, contracture release, osteocapsular arthroplasty.
- ASA I-III
- Age>65
- Cognitively challenged patients
- Severe COPD
- Patients who, on their own or with the assistance of a caregiver, are not confident of being able to remove the local anesthetic infusion catheter at home
- Psychiatric history
- Allergy to ropivacaine.
- Opioid tolerance (>60mg oral morphine or equivalent/day)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Range of Motion 1 year Range of motion at the elbow will be measured vs. baseline to determine surgical success.
- Secondary Outcome Measures
Name Time Method Post-operative analgesia 3 days Pain scores, by visual analogue scale, will be used to determine patient satisfaction with analgesia to day 3 after surgery.
Trial Locations
- Locations (1)
Toronto Western Hospital
🇨🇦Toronto, Ontario, Canada
Toronto Western Hospital🇨🇦Toronto, Ontario, Canada